DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2DR REDDYS LABS SA
02 7STRIDES PHARMA
03 15GRANULES
04 3ABLE
05 7ACCORD HLTHCARE
06 20ACTAVIS ELIZABETH
07 6ACTAVIS LABS FL INC
08 9ALKEM LABS LTD
09 7ALVOGEN
10 2AMNEAL PHARMS
11 7ANI PHARMS
12 13ASCENT PHARMS INC
13 17AUROLIFE PHARMA LLC
14 2AVANTHI INC
15 14AZURITY
16 9BARR
17 6BARR LABS INC
18 2BIONPHARMA
19 5CEDIPROF INC
20 6COREPHARMA
21 13ELITE LABS INC
22 11EPIC PHARMA LLC
23 1FERNDALE LABS
24 2GLAXOSMITHKLINE
25 2GLENMARK PHARMS LTD
26 1HALSEY
27 6IMPAX LABS
28 3IMPAX LABS INC
29 5LANNETT
30 13LANNETT CO INC
31 6LUPIN
32 1MAST MM
33 6NEOS THERAPS
34 1NEOS THERAPS INC
35 13NESHER PHARMS
36 7NORVIUM BIOSCIENCE
37 2NOVAST LABS
38 2NOVEL LABS INC
39 4NOVEN PHARMS INC
40 9NUVO PHARM
41 6ORYZA
42 6PH HEALTH
43 3PHARMOBEDIENT
44 1PRASCO
45 2PRINSTON INC
46 1PUREPAC PHARM
47 15RHODES PHARMS
48 2SANALUZ
49 5SANDOZ
50 5SENORES PHARMS
51 2SHIRE
52 2SMITH KLINE & FRENCH
53 24SPECGX LLC
54 6SUN PHARM INDS INC
55 13SUN PHARM INDUSTRIES
56 10TAKEDA PHARMS USA
57 17TEVA
58 4TEVA PHARMS
59 4TEVA PHARMS USA
60 7TEVA WOMENS
61 8TRIS PHARMA INC
62 3UCB INC
63 2VITARINE
64 7WINDER LABS LLC
65 7ZYDUS PHARMS
01 154CAPSULE, EXTENDED RELEASE;ORAL
02 5CAPSULE;ORAL
03 1ELIXIR;ORAL
04 2SOLUTION;ORAL
05 2SUSPENSION, EXTENDED RELEASE;ORAL
06 4SYSTEM;TRANSDERMAL
07 4TABLET, EXTENDED RELEASE;ORAL
08 12TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
09 5TABLET, ORALLY DISINTEGRATING;ORAL
10 238TABLET;ORAL
11 2Tablet; Oral
01 136DISCN
02 285RX
03 8Blank
01 1ADDERALL 10
02 1ADDERALL 12.5
03 1ADDERALL 15
04 1ADDERALL 20
05 1ADDERALL 30
06 1ADDERALL 5
07 1ADDERALL 7.5
08 1ADDERALL XR 10
09 1ADDERALL XR 15
10 1ADDERALL XR 20
11 1ADDERALL XR 25
12 1ADDERALL XR 30
13 1ADDERALL XR 5
14 1ADZENYS ER
15 6ADZENYS XR-ODT
16 6AMPHETAMINE
17 32AMPHETAMINE SULFATE
18 2BENZEDRINE
19 1BIPHETAMINE 12.5
20 1BIPHETAMINE 20
21 1BIPHETAMINE 7.5
22 8DELCOBESE
23 3DEXAMPEX
24 2DEXEDRINE
25 3DEXEDRINE SPANSULE
26 244DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
27 6DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
28 6DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAM
29 71DEXTROAMPHETAMINE SULFATE
30 2DEXTROSTAT
31 1DYANAVEL XR
32 1DYANAVEL XR 10
33 1DYANAVEL XR 15
34 1DYANAVEL XR 20
35 1DYANAVEL XR 5
36 2EVEKEO
37 5EVEKEO ODT
38 1FERNDEX
39 4MYDAYIS
40 4XELSTRYM
01 375No
02 46Yes
03 8Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 1999-05-13
Application Number : 40299
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AA
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2019-08-05
Application Number : 212619
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
